Symrise Ag

Haarmann & Reimer Gmbh

Symrise Gmbh & Co Kg

Elc Management LLC

Oskar Koch

Jakob Peter Ley

Roland Langner

Martina Herrmann

Imke Meyer

Marcus Rudolf Götz

Horst Surburg

Walter Kuhn

William Johncock

Gabriele Vielhaber

Dominik Stuhlmann

Johannes Panten

Dietmar Schatkowski

Jean Krutmann

Harry Erfurt

Peter Esser

Alfred Krempel

Gerhard Schmaus

Rudolf Hopp

Nadine A Pernodet

Heinz-Jurgen Bertram

Sabine Lange

Tobias Vössing

Erich Dilk

Holger Joppe

Andreas Martin

Ralf Bertram

Jan Looft

Vijayanand Chandrasekaran

Benoit Join

Angela Köckritz

Angela Koeckritz

Kelly Dong

Hans-Ulrich Funk

Chia-wen Chen

Horst Sommer

Claudia Gömann

Gerhard Senft

Peter Worner

Nikolas Bugdahn

Aurélie Trunet

Marcus Betzer

Alfred Korber

Horst Finkelmeier

Edison Diaz Gomez

Axel Schöning

Werner Marks

Reinhard Eckelt

Bernd Fiebich

Michael Kant

Stephan Hillers

Matthias Winkler

Sigrid Evert

Caroline Baptiste

Burghard Wilkening

Nadine Hillebrand

Gerald Reinders

Helko Oertling

Christel Jahnke

Karl-Georg Fahlbusch

Udo Armbruster

Michael Bartoszek

Brigitte Lange

Regina Bienert

Atia Hanan

Jared Klein

Jingyu Huang

Chia-Wen Chen

Hanan Atia

Joahnnes Panten

Claudia GÖMANN

Bodo Jahnke

Described are specific mixtures comprising one or more (cannabinoid) compounds of the formula (A) and/or one or more of their salts as well was methods for their production. Further described are a compound of the formula (A), a salt of the formula (A) and a corresponding mixture for use as a medicament or, respectively, for use in a method for therapeutic treatment of the human or animal body. Described are also corresponding pharmaceutical formulations, cosmetic preparations and preparations for pleasure and/or nutrition, suitable for consumption, as well as methods for producing CBDV and THCV.

Mixtures of cannabinoid compounds, and production and use thereof

The present invention relates to a method of producing a compound of formula (I) or a salt of a compound of formula (I). The invention also relates to a compound of formula (I) or a salt of a compound of formula (I) for use in a therapeutic method to achieve one or more therapeutic effects as well as for use in the treatment and/or prevention of certain diseases. Furthermore, the invention provides a pharmaceutical composition comprising one or more compound(s) of formula (I) or salt(s) of compound(s) of formula (I).

Synthesis of (+)-cannabinoids and their therapeutic effects

Suggested is a cosmetic blend, comprising or consisting of (a) at least one TRPV1 and/or TRPV3 modulator and (b1) at least one 1,2-alkandiol having 5 to 12 carbon atoms and/or (b2) at least one polyol having 3 to 12 carbon atoms and 3 to 6 hydroxyl groups.

Cosmetic blends

A fragrance mixture and its applications, in particular perfume oils, cosmetic agents, application agents or washing and cleaning agents, containing a sensory effective amount of (i) (E)-2-methyl-but-2-endicarboxylic acid diethyl ester, (ii) (Z)-2-methyl-but-2-endicarboxylic acid diethyl ester or (iii) 2-methylenebutanedicarboxylic acid diethyl ester and mixtures thereof and analogous esters derived from these compounds and mixtures.

Fragrance mixture

Described are specific mixtures comprising one or more (cannabinoid) compounds of the formula (A) and/or one or more of their salts as well was methods for their production.  Further described are a compound of the formula (A), a salt of the formula (A) and a corresponding mixture for use as a medicament or, respectively, for use in a method for therapeutic treatment of the human or animal body. Described are also corresponding pharmaceutical formulations, cosmetic preparations and preparations for pleasure and/or nutrition, suitable for consumption, as well as methods for producing CBDV and THCV.

The present invention relates to a method for producing a substituted alkyl cycloalkanone, comprising the alkylation of a cycloalkanone with an alkene derivative in the presence of a metal oxide, where n is 2 to 20, m is 0 to 10, and R is a functional group.

Method for preparing substituted alkyl cycloalkanones

The invention relates generally to new compounds of formula (I), wherein R, R', R, R&#x2032;, R, R&#x2032;, RR&#x2032;, R, R&#x2032;, R, Rare independently of one another and denote hydrogen, hydroxyl, Cto C-alkyl group or Rand Rform together a C5-C6 ring system, and wherein n=0, 1, 2, 3, or 4. Moreover, the invention relates to the use of one or more compounds of formula (I) in cosmetic or pharmaceutical compositions, which are preferably dermatological compositions and are preferably used topically. 

Succinate derivatives

A method is described for producing a compound having the formula (I) or an admixture comprising a compound having the formula (I),having the following steps: where Rand Rindependently of each other signify hydrogen or a branched or unbranched alkyl group having from 1 to 12 carbon atoms andwhere R, R, R, R, R, R, R, Rand Rindependently of each other signify hydrogen, hydroxy or a branched or unbranched alkyl or alkoxy group having from 1 to 12 carbon atoms and An admixture comprising a compound of the formula (I) and other components is further described.

Method for producing indanone derivatives

Specific compositions comprising one or multiple (cannabinoid) compound(s) of formula (A) and/or one or multiple salt(s) thereof are described as well as methods for their manufacture.  A compound of formula (A), a salt of formula (A) and a respective composition for use as medicine and for use in a method for the therapeutic treatment of the human or animal body, respectively, are also described. Furthermore, corresponding pharmaceutical formulations, cosmetic preparations and foodstuff and/or gourmet or snack preparations fit for consumption as well as a method for the manufacture of delta-9-tetrahydrocannabinol are described.

This invention relates to cosmetic and pharmaceutical preparations comprising 

Use of dihydrodehydrodiisoeugenol and preparations comprising dihydrodehydrodiisoeugenol

The present invention relates to formulations having an irritation-reducing action, corresponding cosmetic and pharmaceutical products as well as associated methods and uses thereof.

Formulation with irritation reducing action comprising bisabolol and [6]-paradol

A process for the preparation of 1,2-pentanediol by reaction of a starting material comprising one or both compounds from the group consisting of furfuryl alcohol and furfural with hydrogen in the presence of a first heterogeneous catalyst is described.

Method for producing 1,2-pentanediol

The invention relates to a cosmetic, dermatological or pharmaceutical preparation, containing one, two or more compounds of formula (I) and/or a pharmaceutically acceptable salt of a compound of this type, 

Use of pterocarpans as active anti-cellulite ingredients

Antimicrobially active 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone of the following formula 1 is described, as is a method for producing this compound and the use thereof as an antimicrobial active ingredient. 

3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and use thereof as an antimicrobial active ingredient

The invention relates to the field of aryl hydrocarbon receptor (Ah receptor; AhR) antagonists and their uses.

AH receptor antagonists

Growing community of inventors

Göttingen, Germany

Oskar Koch